23andMe has raised a substantial $115 million in series E funding led by Fidelity Management and Research Company, with participation from new investors Casdin Capital, WuXi Healthcare Ventures and Xfund, as well as existing investors such as Google Ventures. The personal genomics and biotechnology company was founded in 2006 by Linda Avey and Anne Wojcicki, […]...